Scientific Center for Family Health and Human Reproduction Problems, Russia Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT02680275
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Inna I. Kovalenko

Active Ingredients

Drugs in Phase 3 Trials (1)

placental tissue extract (1 trial)

Drugs in Other Trials (1)

dead sea peloid (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2